ProShares Ultra Nasdaq Biotechnology

Lønnsomhet i seks måneder: -17.87%
Industri: Leveraged Equities

Sammenligning av ETFer

	ProShares Ultra Nasdaq Biotechnology	Vanguard Intermediate-Term Corporate Bond ETF	Vanguard Total International Bond ETF
Eiendeler	89464150.00	51944943773.00	60368447110.00
Pris	53.385	80.33	48.93
Årlig avkastning	51.7	0.1996	0.6583
3 års avkastning	-30.53	-13.1	-12.44
5 års avkastning	61.71	-10.89	-15.39
Kommisjon	0.95	0.04	0.07
Utbytte	0.85651	4.17	4.76
Gjennomsnittlig P/E	20.39319	0.33	0.00
Antall verdipapirer i ETF	206	511	6
Kategori	Leveraged Equities	Corporate Bonds	Total Bond Market

Enkel graf Avansert tidsplan

Enkel graf Avansert tidsplan

Enkel graf Avansert tidsplan

ProShares Ultra Nasdaq Biotechnology

Vanguard Intermediate-Term Corporate Bond ETF

Vanguard Total International Bond ETF

Bedrift	Dele, %
Gilead Sciences	6.44
Regeneron	5.73
Amgen	5.37
Vertex	5.14
AstraZeneca PLC	2.48
Alnylam Pharmaceuticals, Inc.	2.29
Biogen	1.91
Moderna	1.75
Illumina	1.39
Summit Therapeutics Inc.	1.15
argenx SE	1.13
Sanofi	1.08
United Therapeutics Corporation	1.01
Incyte	0.9731
Viatris	0.9415

Bedrift	Dele, %
Dynatrace, Inc.	0.28
Microsoft Corporation	0.23
Wipro Limited	0.15
AbbVie	0.13
American Express	0.11
DuPont	0.1
T-Mobile US	0.09
Amazon	0.09
Alibaba Group Holding Limited	0.07
Costco Wholesale	0.07
Salesforce	0.07
Deutsche Bank AG	0.07
Dollar Tree	0.07
MetLife	0.07
ServiceNow	0.07